Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin

✍ Scribed by Matthew C. Riddle; Robert R. Henry; Terri H. Poon; Bei Zhang; Susanna M. Mac; John H. Holcombe; Dennis D. Kim; David G. Maggs

• Publisher: John Wiley and Sons
• Year: 2006
• Tongue: English
• Weight: 161 KB
• Volume: 22
• Category: Article
• ISSN: 1520-7552
• DOI: 10.1002/dmrr.646